Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huoxiang Zhengqi oral liquid for prevention of chemotherapy-induced nausea and vomiting
ChiCTR2000040123Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Oct 2020
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Huoxiang Zhengqi in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Complete response rate of CINV during risk phase and Complete response rate of CINV outside risk phase. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
Huoxiang Zhengqi
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on ChiCTR2000040123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040123.